Ratio Analysis on Different Pharmaceuticals in Bangladesh Essay Example

Ratio Analysis on Different Pharmaceuticals in Bangladesh Paper Table of Content 1. Letter of transmittal†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦03 2. Introduction †¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦04 3. Ratio Analysis†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦.. 06 4. Liquidity†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦07 i. Current ratio†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦08 ii. Quick Ratio†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦.. 09 5. Asset management†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦.. 10 iii. Inventory turnover†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦11 iv. Days sales outstanding (DSO)†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚ ¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦12 v. Fixed asset turnover†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦13 vi. Total assets turnover†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦14 6. Debt management†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦.. 15 vii. Total debt to total assets†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦16 viii. Times-interest-earned (TIE)†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦17 ix. EBITDA coverage†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦18 7. Profitability†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦.. 19 x. Profit margin on sales†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦20 xi. Basic earning power (BEP)†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦21 xii. Return on total assets (ROA)†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦22 xiii. Return on common equity (ROE)†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦23 8. Market value†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦.. 24 xiv. Price/earning (P/E)†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â ‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦25 xv. Price/cash flow†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦26 xvi. Market/book (M/B)†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦27 9. Overall Financial Summary†¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦Ã¢â‚¬ ¦. 28 10. Balance sheet, cash follow and income statement of BEXIMCO LTD 11. Balance sheet, cash follow and income statement of SQUARE LTD 12. Balance sheet, cash follow and income statement of Renata LTD Acknowledgements At first our thanks goes to Mr. S. M. Abdus Shakur, Lecturer, School of Business, Presidency University, for giving us the responsibility to prepare this report which we found to be a rather interesting topic to work on, and for the help to prepare the report as well. We got help from many people in the context of preparing this report and some of the persons have been very helpful and cooperative with information and suggestions. We will write a custom essay sample on Ratio Analysis on Different Pharmaceuticals in Bangladesh specifically for you for only $16.38 $13.9/page Order now We will write a custom essay sample on Ratio Analysis on Different Pharmaceuticals in Bangladesh specifically for you FOR ONLY $16.38 $13.9/page Hire Writer We will write a custom essay sample on Ratio Analysis on Different Pharmaceuticals in Bangladesh specifically for you FOR ONLY $16.38 $13.9/page Hire Writer And lastly, we would like to thank each other, means the group members for helping each other whenever we have to get help. Introduction: Financial Ratio Analysis is a tool used by individuals to conduct a quantitative analysis of information  in a companys financial statements. Ratios are  calculated from current year numbers and are then compared to previous years, other companies, the industry, or even the economy to judge the performance of the company. Ratio analysis is predominately used by proponents of fundamental analysis. Financial ratios are designed to help one evaluate financial statement and by comparing the results it must pay to the income it has available for payment such comparisons are made by ratio analysis. Here we take three companies from the same industry to analyze their financial statement and we also compare the findings with the total pharmaceuticals industry average. The companies name we took are- 1. BEXIMCO PHARMACEUTICALS LIMITED. 2. SQUARE PHARMACUTICALS LTD. 3. RENATA LIMITED. 4. AMBEE PHARMACEUTICALS LTD. Ratio Analysis Financial ratios are useful indicators of a firms performance and financial situation. Financial ratios can be used to analyze trends and to compare the firms financials to those of other firms. Financial ratios can be classified according to the information they provide. The following types of ratios frequently are used: 1. Liquidity ratios 2. Asset management ratios 3. Debt management ratios 4. Profitability ratios 5. Market value ratios LIQUIDITY RATIOS Liquidity ratios are the first ones to come in the picture. These ratios actually show the relationship of a firm’s cash and other current assets to its current liabilities. Two ratios are discussed under Liquidity ratios. They are: 1. Current ratio 2. Quick/ Acid Test ratio. 1. Current ratio: This ratio indicates the extent to which current liabilities are covered by those assets expected to be converted to cash in the near future. Current assets normally include cash, marketable securities, accounts receivables, and inventories. Current liabilities consist of accounts payable, short-term notes payable, current maturities of long-term debt, accrued taxes, and other accrued expenses (principally wages). Current Ratio = Current Assets/Current Liabilities BEXIMCO =28618916542602032267 1. 10 times Square=44118364363500845103 =1. 26 times Renata=988092820717068650 =1. 38 times Ambee=218724505222145758 =0. 985 times Industry average=1. 18 times 2. Quick/ Acid Test ratio: This ratio indicates the firm’s liquidity position as well. It actually refers to the extent to which current liabilities are covered by those assets except inventories. Quick Ratio = (Current Assets-Inventories)/Current Liabilities BEXIMCO =28 61891654-15052880932602032267 =1. 04 times Square=4411836436-20267363223500845103 =1. 20 times Renata=988092820-959414590717068650 =0. 04 times Ambee=218724505-135899190222145758 =0. 37 times Industry Average=0. 66 times ASSET MANAGEMENT RATIOS Asset management ratios are the financial statement ratios that measure how effectively a business uses and controls its assets. Below are discussed five types of asset management ratios: 1. Inventory turnover ratio 2. The day’s sales outstanding 3. Fixed asset turnover ratio 4. Total asset turnover ratio 1. Inventory turnover ratio: The ratio is regarded as a test of efficiency and indicates the rapidity with which the company is able to move its merchandise. Inventory turnover ratio = Gross Turnover / Inventories BEXIMCO = 40101670591505288093 =2. 66 times Square= 82310975252026736322 =4. 06 times Renata=3089746417959414590 =3. 22 times Ambee=240726296135899190 =1. 77 times Industry Average=2. 93 times 2. The Days Sales Outstanding: The Days Sales Outstanding ratio shows both the average time it takes to turn the receivables into cash and the age, in terms of days, of a companys accounts receivable. This ratio is of particular importance to credit and collection associates. Days Sales Outstanding (DSO) = Trade Debtors/ (Annual gross turnover/365) BEXIMCO =5039164014010167059/365 =19. 23 Days Square=3602456469565715902/365 =13. 75 Days Renata=3442269333089746417/365 =40. 66 Days Ambee= 38179778240726296/365 =57. 89 days Industry Average=32. 88 days 3. Fixed asset turnover ratio: The Fixed Asset Turnover ratio measures the effectiveness in generating Net Sales revenue from investments in Net Property, Plant, and Equipment back into the company evaluates only the investments. Fixed assets turnover ratio (FATO) = Gross Turnover / Net fixed assets Beximco=401016705911957773787 =0. 34 times Square=82310975258291290984 =0. 99 times Renata=30897464771656161962 =1. 87 times Ambee=24072629660695282 =3. 97 times Industry Average=1. 79 times 4. Total asset turnover ratio: The Total Asset Turnover is similar to fixed asset turnover since both measures a companys effectiveness in generating sales revenue from investments back into the company. Total Asset Turnover evaluates the efficiency of managing all of the companys assets. Total assets turnover ratio (TATO) = Gross Turnover/Total Assets Beximco=401016705914819665441 0. 27 times Square=825784373912703127420 =0. 65 times Renata=30897464173162232934 =0. 98 times Ambee=24072629657247033 =4. 21 times Industry Average=1. 53 times DEBT MANAGEMENT RATIOS Debt management ratios reveal 1) the extent to which the firm is financed with debt and 2) its likelihood of defaulting on its debt obligations. These ratios include: 1. Debt ratio, 2. Times-Interest-Earned (TIE) ratio, 3. EBITDA Coverage . 1. Debt ratio: The ratio of total debt to total assets, generally called the debt ratio, measures the percentage of funds provided by the creditors. Debt ratio = Total Debt / Total Assets Beximco=436946329614819665441 =29 % Square=428608671512703127420 =34 % Renata=15001595773162232934 =47 % Ambee= 4800990157247033 =83% Industry Average=48. 25% 2. Times-Interest-Earned (TIE) ratio: This ratio measures the extent to which operating income can decline before the firm is unable to meet its annual interest cost. EBIT = Earnings before Interest and Tax TIE ratio = EBIT / Interest Charges Beximco=963775308249654298 =3. 86 times Square=2908395181397135963 =7. 32 times Renata=69719063387270665 =7. 99 times Ambee =78642302395026 3. 28 times Industry Average=5. 61 times 3. The EBITDA coverage ratio: The EBITDA coverage ratio shows if earnings are able to satisfy all financial obligations including leases and principal payments. (EBITDA is short for earnings before interest, taxes, depreciation, and amortization. ) EBITDA Ratio = EBITDA + Lease Payment/ Interest + Principal Payment + Lease Payment Beximco=963775308+5887353+30993608+10302868 249654298+3556423568 =0. 29 times Square=2908395181+454290404+57334928+140936267397135963+2279693991 =0. 56 times Renata=697190633+1628151487270665 =1. 17 times Ambee=7864230+9614002395026+0+7864230 =0. 86 times Industry Average=0. 72 times PROFITIBILITY RATIO: Profitability is the net result of a number of policies and decisions. Profitability ratios show the combined effects of liquidity, asset management and debt on operating results. There are four important profitability ratios that we are going to analyze: 1. Profit Margin on sales 2. Basic Earning power (BEP) 3. Return on Asset 4. Return on Equity 1. Profit Margin on Sales: Profit Margin on Sales gives us the net profit that the business is earning per dollar of sales. The equation is as follows: Profit margin on Sales = Net income available to the stockholders / Sales Beximco=5453412734010167059 =13. 6 % Square=13818630938257843739 =16. 7 % Renata=4331458043089746417 =14 % Ambee=6347155240726296 =2. 64% Industry Average=11. 735% 2. Basic Earning Power (BEP): The ratio indicates the ability of the firm’s assets to generate operating income. The equation is as follows: Basic Earning Power = EBIT / Total Assets Beximco=96377530814819665441 =6. 5 % Square=290839518112703127420 =22. 9 % Renata=6971906333162232934 =22 % Ambee=786423057274033 =13. 3% Industry Average=16. 28% 3. Return on Total Assets (ROA): Return of total asset measures the amount of Net Income earned by utilizing each dollar of Total Assets. The equation is: Return on Total Assets (ROA) = Net income available to total common shareholders / Total assets Beximco=54534127314819665441 =3. 7 % Square=138186309312703127420 =10. 9 % Renata=4331458043162232934 =13. 7 % Ambee=63471555727 4033 =11. 08% Industry Average=9. 85% 4. Return on Equity (ROE): Return on Equity measures the amount of Net Income earned by utilizing each dollar of Total common equity. It is the most important of the â€Å"Bottom line† ratio. By this, we can find out how much the shareholders are going to get for their shares. The equation is: Return on Equity (ROE) = Net income available to common shareholders / Total common equity Beximco=54534127310450202145 =5. 2% Square=13818630938417040705 =16. 4% Renata=433145804155075461 =2. 79% Ambee=634715546527981 =13. 64% Industry Average=9. 51% MARKET VALUE RATIOS The final group of ratios, the market value ratios relates the firm’s stock price to its earnings, cash flow and book value per share. These ratios give management an indication of what investors think of the company’s past performance and future prospects. In this section, we are going to have a discussion mainly on three types of ratios: 1. Price/Earnings Ratio 2. Price/ Cash flow Ratio 3. Market/ Book Ratio 1. Price/ Earnings ratio: The Price/ Earnings ratio (price-to-earnings ratio) of a stock is a measure of the price paid for a share relative to the income or profit earned by the firm per share. P/E ratio = Price per share / earnings per share Beximco=104. 33 =2. 309 times Square=100114. 47 =0. 87 times Renata=100374. 44 =0. 267 times Ambee=103. 17 =3. 15 times Industry Average=1. 65 times 2. Price/ Cash Flow ratio: This ratio indicates the amount investors will pay for Tk. 1 of cash flow. The equation for this ratio is shown below: Price/ Cash flow ratio = Price per share/Cash flow per share Beximco=10(545341+147183829)/1045020214 =70. 73 times Square=100(1381863093+652561599)/18170407 =1. 11 times Renata=100(433145804+16281514)/1156787 =3. 88 times Ambee= 10(6347155+57274033)/46527981 =7. 31 times Industry Average=20. 6 times 3. Market/ Book ratio: The ratio of stock’s market price to its book value. The Equation is: Market/Book ratio (M/B) = Market price per share / Book value per share Beximco=167. 7104502021451045020214 =16. 77 times Square=3151. 258417040705/18170407 =6. 80 times Renata=7789. 75115678700/1156787 =77. 89 times Ambee=12910 =12. 9 times Industry Average=28. 59 times OVERALL FINANCIAL SUMMARY After analyzing all the ratios, we have found out the following information: 1. Liquidity Ratios: In the liquidity ratio we can see that both current atio and quick ratio is good in average for Square comparing with the industry average. Renata’s current ratio is quite well, but it seems that the company has too much inventories, so, the quick ratio got lower. 2. Asset Management Ratios: for the asset management ratios, we can see that for the first two, Square is in a good shape. But for the asset turnover ratios, Ambee plays a good role. Meaning that Square is good in turning its current assets to liquidity, and Ambee is good at moving its long term assets to liquidity. 3. Debt Management Ratios: in Debt management ratio analysis, we can see that for debt ratio and TIE ratio, both Beximco is in a good shape on an average. Bot for the EBITDA Coverage ratio, Renata does the best. But, as a whole, we can say that Beximco is quite good in managing its debt. 4. Profitability Ratios: for the profitability ratios, we can see that square is very good at both Profit margin on sales, and BEP ratios. At ROA, Square is okay, but Renata and Ambee are very good. Again for ROE, Square is extra ordinarily good. So, we can say that Squrae is very good at managing and earning profit. 5. Market Value Ratios: here we see that for the first two analyses, Beximco’s market value is higher, but for the last one, renata’s valu is higher, but Beximco’s was okay. So, we can say that in terms of market value, Beximco is good on average. From the total analysis, we can summarize that Square Pharmaceuticals Ltd and Beximco Pharmaceuticals Ltd have been doing pretty good throughout the years. It is true that for some cases both the companies are in an okay shape, but it is still pretty much satisfactory. Therefore, we can conclude that both Square Pharmaceuticals Ltd and Beximco Pharmaceuticals Ltd are good enough company to invest on.